Nuernberger Beteiligungs AG
NBG6
ISIN DE0008435967 / Valor 343295
Nuernberger Beteiligungs AG
UMushroom community rating:
About company
Nuernberger Beteiligungs AG, operating primarily through its insurance division, NÜRNBERGER Versicherung, positions itself as a provider of preventative insurance solutions. The company emphasizes the importance of prevention and foresight in its offerings, aiming to protect individuals and communities not only after incidents occur but also by preventing them from happening in the first place. This approach reflects a broader strategy to offer comprehensive protection and security for clients' health, property, income, and loved ones. Nuernberger Beteiligungs AG leverages advancements in science and technology, alongside a deep understanding of potential risks, to deliver insurance products and services designed to reduce worries and enhance the well-being of its customers. The company commits to economic foresight to ensure its long-term presence and reliability for its employees, intermediaries, customers, and shareholders, underlining its mission to support secure living today and in the future.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (06.05.2026):
Nuernberger Beteiligungs AG — Q3 2023 (presenting FY 2022 results). The company’s Baader Investment Conference presentation reports FY 2022 consolidated net income of EUR 78.5 million, gross premiums written of about EUR 3.54 billion, new/additional premiums of EUR 621.7 million, investments of roughly EUR 32.1 billion and an EPS of EUR 6.00. The Board proposes a dividend of EUR 3.50 per share (dividend yield ~4.7%). Rating coverage includes Fitch A+. The life solvency indicator reported at 426% (31/12/2022). Management expects a short‑term decline in 2023 consolidated net income (around EUR 60 million) with mixed segment trends.
Key headline figures (FY 2022)
Consolidated net income: EUR 78.5m; Gross premiums written: ~EUR 3,541.7m; New/additional premiums: EUR 621.7m; Investments: ~EUR 32.1bn; EPS: EUR 6.00; Proposed dividend: EUR 3.50/share (yield ~4.7%).
Capital strength & ratings
Life solvency indicator (NLV) very strong at 426% (31/12/2022, without transitionals). Fitch rating cited as A+ in the presentation, underscoring a comfortable capital and rating position.
Segment performance highlights
Life: continued profitability gains in biometric (e.g., occupational disability) products and strong underwriting results. Health: above‑market growth in supplementary health insurance and profitable corporate group partnerships. P&C: premium growth but profitability hit by inflation and major fire claims.
P&C profitability
Combined ratio (gross) deteriorated in 2022 to c. 107.1% (from lower levels in prior years), reflecting higher claims costs and inflationary pressure on loss severities.
Shareholder return
Dividend maintained/raised to EUR 3.50 per share; EPS EUR 6.00 for 2022. Presentation emphasizes a long track record of stable dividends and shareholder participation.
2023 outlook (management guidance)
Management expects short‑term earnings decline with consolidated net income “in the order of EUR 60m.” Forecasted trends: life new business to fall significantly (slight reduction in life gross premiums), while P&C and health gross premiums are expected to grow; banking services net commission income expected to decline noticeably.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1566 M
Market cap (USD)
1
Daily traded volume (Shares)
49.4 / 47
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
